Clinical evaluation of [18F]pitavastatin for quantitative analysis of hepatobiliary transporter activity-Reference-Cited by-同舟云学术

Clinical evaluation of [18F]pitavastatin for quantitative analysis of hepatobiliary transporter activity

Published:2022-06 Issue: Volume:44 Page:100449
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Nakaoka Takayoshi^ORCID,Kaneko Ken-ichi,Irie Satsuki,Mawatari Aya,Igesaka Ami,Uetake Yuta^ORCID,Ochiai Hidenori^ORCID,Niwa Takashi^ORCID,Yamano Emi,Wada Yasuhiro,Tanaka Masaaki,Kotani Kohei,Kawahata Hideki,Kawabe Joji,Miki Yukio^ORCID,Doi Hisashi,Hosoya Takamitsu,Kazuya Maeda^ORCID,Kusuhara Hiroyuki,Sugiyama Yuichi,Watanabe Yasuyoshi

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference34 articles.

1. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake;Niemi;Pharmacol Rev,2011

2. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption;Shitara;Biopharm Drug Dispos,2013

3. Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs;Maeda;Biol Pharm Bull,2015

4. Importance of hepatic transporters in clinical disposition of drugs and their metabolites;Patel;J Clin Pharmacol,2016

5. Use of PET imaging to evaluate transporter-mediated drug-drug interactions;Langer;J Clin Pharmacol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [18F]FSW-100 for clinical applications;EJNMMI Radiopharmacy and Chemistry;2024-06-03

2. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

3. Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics‐Informed Relative Expression Factor Approach;Clinical Pharmacology & Therapeutics;2023-12-18

4. Progress in the Quantitative Assessment of Transporter-Mediated Drug–Drug Interactions Using Endogenous Substrates in Clinical Studies;Drug Metabolism and Disposition;2023-05-11

5. The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans;Pharmacology & Therapeutics;2022-10